Please assess the completion status of the following clinical trial:

Trial Title: ClariFix Cryoablation Clinical Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subject is \>21 years of age~2. Subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion for \>3 months (rTNSS rating of 2 or 3)~3. Subject has signed IRB-approved informed consent form~Exclusion Criteria:~1. Subject has clinically significant anatomic obstructions that limit access to the posterior nose including severe septal deviation, nasal polyps, and sinonasal tumor~2. Subject has a septal perforation~3. Subject has had prior sinus or nasal surgery that significantly alters the anatomy of the posterior nose~4. Subject has had prior head or neck irradiation~5. Subject has active or chronic nasal or sinus infection~6. Subject has active coagulation disorder or patient is receiving anti-coagulants which cannot be safely stopped for 2 weeks~7. Subject has a history of dry nose symptoms~8. Subject is pregnant or lactating~9. Subject is participating in another clinical research study~10. Subject has an allergy or intolerance to anesthetic agent~11. Subject is an active smoker or has been a smoker within the last 6 months~12. Any physical condition that in the investigator's opinion would prevent adequate study participation or pose increased risk

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Cryoablation with the ClariFix device

Based on this trial design, predict the completion outcome and termination type (if applicable).